How to Buy Aurinia Pharmaceuticals Stock
Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc. operates as a commercial-stage biopharmaceutical company, specializing in the development and commercialization of innovative therapies.
Aurinia Pharmaceuticals stock last closed at $16.14, down 0.49% from the previous day, and has increased 104.05% in one year. It has overperformed other stocks in the Biotechnology industry by 1.75 percentage points. Aurinia Pharmaceuticals stock is currently +121.55% from its 52-week low of $7.29, and -4.38% from its 52-week high of $16.88.
There are currently 128.6M shares of AUPH outstanding. The market capitalization of AUPH is $2.08B. In the last 24 hours, 778,000 AUPH shares were traded.
How to Buy Aurinia Pharmaceuticals Stock
Wondering how to invest in Aurinia Pharmaceuticals stock? Here's how.
- Figure out where to buy Aurinia Pharmaceuticals stock: You need to pick an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you choose where to buy Aurinia Pharmaceuticals stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your brokerage account: Pick your method of payment and add your details.
- Analyze Aurinia Pharmaceuticals stock: The Aurinia Pharmaceuticals ticker symbol is AUPH. Is Aurinia Pharmaceuticals stock a good investment? Should you buy shares of AUPH? How do AUPH's underlying business fundamentals look? Do top analysts think Aurinia Pharmaceuticals is a good buy? Why has AUPH's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if AUPH is a good stock to buy).
- Place your AUPH purchase: Decide if you will purchase AUPH shares at the current market price or use a limit order to buy AUPH stock at a specific price.
- Keep tabs on your investment in AUPH: Create a watchlist to monitor your position in Aurinia Pharmaceuticals stock.
Step 1: Figure out where to buy Aurinia Pharmaceuticals stock
You will need a brokerage account in order to access the NASDAQ market and buy AUPH stock.
Our recommended brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global markets: From Technology to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the right brokerage, it's time to fill out some personal information so you can buy AUPH stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open your new trading account.
- Submit your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you've finished signing up on the best stock market app, you can securely and quickly fund your account:
Watch the tutorial below if you need help depositing funds into your brokerage account.
Step 4: Analyze Aurinia Pharmaceuticals stock
After you have decided on the best place to buy Aurinia Pharmaceuticals stock, it's very important to research their stock before you invest, so you actually understand the risk as well as the opportunity.
Aurinia Pharmaceuticals stock quick numbers
Aurinia Pharmaceuticals Due Diligence Checks
WallStreetZen was designed to help part-time investors do more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on AUPH's stock page.
Is AUPH stock undervalued or overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge AUPH's intrinsic value.
Using relative valuations methods:
- AUPH may be undervalued based on its P/E ratio of 7.24x, relative to Biotechnology industry P/E ratio of 14.91x
- AUPH may be undervalued based on its P/B ratio of 3.66x, relative to Biotechnology industry P/B ratio of 4.94x
You can do more valuation analysis on AUPH's stock here.
Is AUPH a healthy company?
Positive Financial Indicators:
- AUPH has a low debt to equity ratio of 0.28.
- AUPH earnings of $138.01M is not sufficient to cover its interest payments.
- AUPH profit margin has gone up from 16.1% to 100% in the past year.
- There are more short-term assets than short-term liabilities on the AUPH balance sheet.
- AUPH's operating cash flow of $166.92M allows it to safely service it's debt of $68.64M.
- There are more short-term assets than long-term liabilities on the AUPH balance sheet.
Negative Financial Indicators:
- Total AUPH debt is higher than 5 years ago, relative to shareholder equity.
You can dive deeper into what analysts are forecasting on the Aurinia Pharmaceuticals stock forecast page.
AUPH Momentum
How is AUPH performing as a company?
Last year, AUPH earnings were $298.21M. Over the last 1 years, AUPH's earnings have increased by 668.97% per year. This was faster than the Biotechnology industry average of 12.59%.
Last year, AUPH revenue was $298.30M. Over the last 5 year, AUPH's revenue has increased by 42.37% per year. This was faster than the Biotechnology industry average of 32.15%.
Find out more about AUPH's earnings and revenue performance here.
Who is buying/selling AUPH?
Over the last year, insiders at AUPH have bought more shares than they have sold.
Kevin Tang, Chief Executive Officer of AUPH, was the latest AUPH insider to buy. They bought $3,147,756.40 worth of AUPH shares on Jun 2, 2026.
Get more info about who owns AUPH shares here.
Does AUPH stock generate passive income?
No, Aurinia Pharmaceuticals doesn't provide an income stream by paying out dividends.
What do other traders have to say about AUPH?
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your AUPH purchase
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly the best for newer investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at an exact dollar amount, use a limit order.
Press the Open Trade button and your broker will place the order.
If you need more info about investing in stocks on eToro, click the helpful video below:
Step 6: Keep tabs on your investment in AUPH
Now that you own some AUPH shares, you'll want to stay up-to-date on your new company.
Create a watchlist to get notified of the latest news about your AUPH stock.
AUPH Feed
How to Buy Stock in Aurinia Pharmaceuticals
To reiterate, here are the 6 steps for buying Aurinia Pharmaceuticals stock:
- Figure out where to buy Aurinia Pharmaceuticals stock
- Create your brokerage account
- Fund your brokerage account
- Analyze Aurinia Pharmaceuticals stock
- Place your AUPH purchase
- Keep tabs on your investment in AUPH
If you require a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to track your new investment in Aurinia Pharmaceuticals, add AUPH to your watchlist below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.